DE NOVO DONOR-SPECIFIC HLA ANTIBODIES IN LOW RISK PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS

被引：0
|
作者：
Yilmaz, Alev [1 ]
Oguz, Fatma Savran [2 ]
Usta, Sebahat [2 ]
Yildirim, Zeynep Yuruk [1 ]
Pehlivanoglu, Cemile [1 ]
Kekik, Cigdem [2 ]
Emre, Sevinc [1 ]
机构：
[1] Istanbul Univ, Istanbul Fac Med, Dept Pediat Nephrol, Istanbul, Turkey
[2] Istanbul Univ, Istanbul Fac Med, Dept Med Biol, Istanbul, Turkey
来源：
PEDIATRIC NEPHROLOGY | 2015年 / 30卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
P - 476
引用
收藏
页码：1724 / 1724
页数：1
相关论文
共 50 条
  • [21] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES: BIOMARKERS OF PANCREAS TRANSPLANT FAILURE
    Mittal, Shruti
    Page, Suzanne L.
    Gilbert, James
    Friend, Peter J.
    Sharples, Edward
    Fuggle, Susan V.
    TISSUE ANTIGENS, 2013, 81 (05): : 274 - 274
  • [22] De Novo Donor-Specific HLA Antibodies: Biomarkers of Pancreas Transplant Failure
    Mittal, S.
    Page, S. L.
    Friend, P. J.
    Sharples, E. J.
    Fuggle, S. V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (07) : 1664 - 1671
  • [23] The Impact of Tacrolimus IPV and TTR on the Development of De Novo Donor-specific Antibodies in Kidney Transplant Recipients
    Xu, D.
    Richards, K.
    Zheng, K.
    Patel, H.
    Cardarelli, F.
    Pena, J. A.
    Aala, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 844 - 844
  • [24] Does Everolimus Increase Donor-Specific HLA Antibodies in Kidney Transplant Recipients?
    Pascual, J.
    Arns, W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (09) : 2561 - 2562
  • [25] DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant
    Tagliamacco, Augusto
    Cioni, Michela
    Comoli, Patrizia
    Ramondetta, Miriam
    Brambilla, Caterina
    Trivelli, Antonella
    Magnasco, Alberto
    Biticchi, Roberta
    Fontana, Iris
    Dulbecco, Pietro
    Palombo, Domenico
    Klersy, Catherine
    Ghiggeri, Gian Marco
    Ginevri, Fabrizio
    Cardillo, Massimo
    Nocera, Arcangelo
    TRANSPLANT INTERNATIONAL, 2014, 27 (07) : 667 - 673
  • [26] De-novo donor-specific anti-HLA antibodies in islet cell transplant recipients in Australia
    Hue, S. M.
    Torpy, D. J.
    Bennett, G.
    Kay, T. W.
    Thomas, H. E.
    Goodman, D.
    Loudovaris, T.
    O'Connell, P. J.
    Radford, T.
    Drogemuller, C. J.
    Coates, P. T.
    TRANSPLANTATION, 2016, 100 (07) : S405 - S405
  • [27] Basiliximab is associated with a lower incidence of De novo donor-specific HLA antibodies in kidney transplant recipients: A single-center experience
    Jarmi, Tambi
    Abdelmoneim, Yousif
    Li, Zhuo
    Jebrini, Abdullah
    Elrefaei, Mohamed
    TRANSPLANT IMMUNOLOGY, 2023, 77
  • [28] DE NOVO PRODUCTION OF ANTI-HLA DONOR-SPECIFIC ANTIBODIES IN KIDNEY ALLOGRAFT RECIPIENTS: CLINICAL SIGNIFICANCE
    Piazza, Antonina
    Poggi, Elvira
    Ozzella, Giuseppina
    Caputo, Daniela
    Catalano, Manuela
    Imbroglini, Valentina
    Cremona, Rosanna
    Adorno, Domenico
    TRANSPLANT INTERNATIONAL, 2009, 22 : 132 - 132
  • [29] HLA-DQ heterodimer mismatch number is associated with de novo donor-specific antibody development in pediatric kidney transplant recipients
    Sigurjonsdottir, V. K.
    Wang, L.
    Piburn, K.
    Turudi, D.
    Grimm, P.
    Zhang, M. M.
    HUMAN IMMUNOLOGY, 2024, 85 : 95 - 96
  • [30] The association between human leukocyte antigen eplet mismatches, de novo donor-specific antibodies, and the risk of acute rejection in pediatric kidney transplant recipients
    Ankit Sharma
    Anne Taverniti
    Nicole Graf
    Armando Teixeira-Pinto
    Joshua R. Lewis
    Wai H. Lim
    Stephen I. Alexander
    Anne Durkan
    Jonathan C. Craig
    Germaine Wong
    Pediatric Nephrology, 2020, 35 : 1061 - 1068
12345